Page 30 - 南京医科大学自然版
P. 30
第46卷第8期
·1136 · 南 京 医 科 大 学 学 报 2026年8月
simple rules for diagnosis of ovarian cancer:meta⁃analy⁃ NOP M. Association of serum HE4 with primary tumor
sis[J]. Ultrasound Obstet Gyne,2014,44(5):503-514 diameter and depth of myometrial invasion in endometrial
[5] CAO L,WEI M J,LIU Y,et al. Validation of American cancer patients at rajavithi hospital[J]. Asian Pac J Cancer
college of radiology ovarian ⁃ adnexal reporting and data Prev,2016,17(3):1489-1492
system ultrasound(O⁃RADS US):analysis on 1 054 [11]YUE X,YUE Z N,WANG Y,et al. Value of the Copenha⁃
adnexal masses[J]. Gynecol Oncol,2021,162(1):107- gen index in the diagnosis of malignant adnexal tumors:a
112 meta⁃analysis[J]. Int J Gynecol Obstet,2023,160(2):
[6] HOGDALL C,FUNG E T,CHRISTENSEN I J,et al. A 506-515
novel diagnostic index combining HE4,CA125 and age to [12]刘庆燕,郭海龙,公 莉,等. 哥本哈根指数在绝经前及
distinguish malignant from benign pelvic mass[J]. Gyne⁃ 绝经后卵巢癌诊断中的价值[J]. 肿瘤研究与临床,
col Oncol,2012,127(2):308-315 2020,32(8):569-573
[7] 陈 程,戴 晴. 美国放射学会卵巢⁃附件影像报告和 LIU Q Y,GUO H L,GONG L,et al. Diagnostic value of
数据系统超声风险分层与管理共识指南的解读[J]. 中 Copenhagen index in premenopausal and postmenopausal
华医学超声杂志(电子版),2020,17(11):1051-1060 ovarian cancer[J]. Cancer Research and Clinic,2019,46
CHEN C,DAI Q. Interpretation of the 2020“O⁃RADS US (8):52-55
risk stratification and management system”published by [13] WATROWSKI R,OBERMAYR E,WALLISCH C,et al.
the American College of Radiology[J]. Chin J Med Ultra⁃ Biomarker ⁃ based models for preoperative assessment of
sound(Electronic Edition),2020,17(11):1051-1060 adnexal mass:a multicenter validation study[J]. Cancers,
[8] 吴丽仙,武立萍,王海燕,等. IOTA 简易标准联合卵巢 2022,14(7):1780
癌风险预测模型及多普勒阻力指数诊断卵巢肿瘤的临 [14]丁红帆,徐 桥,赵冰冰,等. 卵巢透明细胞癌CA125应
床价值[J]. 宁夏医科大学学报,2019,41(8):785-788 答、分子靶点与预后关联的多维度研究[J]. 医药前沿,
WU L X,WU L P,WANG H Y,et al. Clinical value of 2025,15(8):11-17
IOTA simple standard combined with ovarian cancer risk DING H F,XU Q,ZHAO B B,et al. A multidimensional
prediction model and doppler resistance index in the diag⁃ study on the relationships among CA125 response ,
nosis of ovarian cancer[J]. Journal of Ningxia Medical molecular targets and prognosis in ovarian clear cell carci⁃
University,2019,41(8):785-788 noma[J]. Journal of Frontiers of Medicine,2025,15(8):
[9] 龚时鹏,陈咏宁,张雅迪,等. 血清 CA125 和 HE4 水平 11-17
及 ROMA、CPH⁃I 模型在鉴别卵巢良恶性肿瘤中的价 [15]李欣欣,李 曼,王 慧,等. 卵巢透明细胞癌的临床与
值对比[J]. 南方医科大学学报,2019,39(12):1393- 超声特征分析[J]. 中国超声医学杂志,2023,39(2):
1401 184-186
GONG S P,CHEN Y N,ZHANG Y D,et al. Comparison LI X X,LI M,WANG H,et al. Clinical and ultrasono⁃
of serum cancer antigen 125,human epididymis protein graphic features of ovarian clear cell carcinoma[J]. Chi⁃
4,ROMA,and CPH⁃I for diagnosis of ovarian cancer in nese Journal of Ultrasound in Medicine,2023,39(2):
Chinese patients with ovarian mass[J]. Journal of Southern 184-186
Medical University,2019,39(12):1393-1401 (收稿:2025-12-23;修回:2026-03-02;录用:2026-03-13)
[10]PRUEKSARITANOND N,CHEANPRACHA P,YANARA⁃ (本文编辑:蒋 莉)

